Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The haemodynamic effect of superficial cervical plexus blockade in patients undergoing carotid endarterectomy under general anaesthesia
ISRCTN ISRCTN52716583
ClinicalTrials.gov identifier
Public title The haemodynamic effect of superficial cervical plexus blockade in patients undergoing carotid endarterectomy under general anaesthesia
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Carotid endarterectomy is performed in patients with severe stenosis (narrowing) of the carotid arteries. The operation improves blood supply to the brain and reduces the risk of stroke in selected patients. In the early post operative period following carotid endarterectomy patients commonly develop blood pressure lability. It is our observation that severe hypertension has decreased whilst hypotension requiring treatment has increased in our patient group over the past 2 years. Two changes in our practise may be contributing to this - first the majority of patients are now beta blocked, secondly our patients are now commonly given a superficial cervical plexus block. We aim to establish the influence of superficial cervical plexus blockade on post operative blood pressure control in these patients.

Our null hypothesis is that there is no clinically significant difference in the mean blood pressures in the first 24 hours following carotid endarterectomy in patients who have been given a superficial cervical plexus block and those who have not.
Lay summary
Ethics approval Ethics approval received on the 22nd July 2004; amendment approved 27th May 2005 (ref: 04/Q1001/21).
Study design Randomised controlled double blind trial
Countries of recruitment United Kingdom
Disease/condition/study domain Blood pressure lability
Participants - inclusion criteria Patients at James Cook University Hospital undergoing carotid endartectomy
Participants - exclusion criteria Patients will be excluded if they:
1. Do not wish to take part
2. Are unfit for a general anaesthetic
3. Have a contraindication to either beta blockers or to being given a local anaesthetic block (e.g. local anaesthetic allergy and bleeding tendency)
Anticipated start date 20/11/2005
Anticipated end date 20/11/2006
Status of trial Stopped
Patient information material
Target number of participants 54
Interventions Patients will receive a superfical cervical plexus block with either 2 mg/kg of laevo-bupivacaine or a placebo block with the equivalent volume of saline
Primary outcome measure(s) Mean systolic blood pressures over the first 24 hours postoperatively.
Secondary outcome measure(s) 1. Need for antihypertensive treatment
2. Need for pressor treatment
3. Cumulative dose of any vasoactive medication
4. Mean pain scores
5. Cumulative opiate requirements

Any cardiovascular, cerebrovascular or other major morbidity or mortality occuring during the time period and any complication potentially related to the superficial cervical plexus block will also be recorded.
Sources of funding James Cook University Hospital (UK) - Anaesthetic Department
Trial website
Publications
Contact name Dr  Gerard  Danjoux
  Address Anaesthetic Department
Cheriton House
James Cook University Hospital
Marton Road
  City/town Middlesbrough
  Zip/Postcode TS4 3BW
  Country United Kingdom
  Tel +44 (0)1642 850850 ext 4600
  Email gerard.danjoux@stees.nhs.uk
Sponsor James Cook University Hospital (UK)
  Address Cheriton House
Anaesthetic Department
Marton Road
  City/town Middlesbrough
  Zip/Postcode TS4 3BW
  Country United Kingdom
  Tel +44 (0)1642 850850 ext 4600
  Email drsarah.platt@virgin.net
Date applied 02/11/2005
Last edited 26/05/2011
Date ISRCTN assigned 28/11/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central